Abstract
Figure 1 was incomplete. The corrected Figure 1 appears here. This version contains all the reasons for discontinuation, including “lack of efficacy.” The “completed study” number and percentage were also corrected, and 2 footnotes were added for clarity:“a Seven hundred seventy-three of 932 (82.9%) patients reconsented and entered COAST-Y after completing their original study.b Six hundred thirty-one of 932 (67.7%) patients completed 156 weeks of treatment and 12 weeks of follow-up.” This correction applies only to the March 1 2023 First Release. The correct text appears in the print and online issues (Figure Presented).
Original language | English (US) |
---|---|
Pages (from-to) | 718 |
Number of pages | 1 |
Journal | Journal of Rheumatology |
Volume | 50 |
Issue number | 5 |
DOIs |
|
State | Published - May 1 2023 |
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology